Recombinant Anti-CSF1 x Anti-IL34 Bispecific Antibody (IgG-Fv) (BSGV-143)

Recombinant Anti-CSF1 x Anti-IL34 Bispecific Antibody (IgG-Fv) is formed by an Immunoglobulin G (IgG) and a fragment variable Fv region, in which the Fc of IgG is engineered by KIH. The Fv region of an anti-CSF1 antibody variable domain is fused to the C terminal of an IgG of anti-IL34 antibody, or vice versa. The format retains desired characteristics of intact antibodies. This BsAb can bind two factors simultaneously. It is designed for the research of Myeloid pathogenic immunological diseases therapy.

Datasheet INQUIRY

Specifications

Targets

CSF1 & IL34

Type

IgG-Fv

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Myeloid pathogenic immunological diseases

Targets

Target 1

CSF1

Gene ID

1435

UniProt ID

A0A024R0A1

Alternative Names

CSF1; colony stimulating factor 1 (macrophage); MCSF; CSF-1; macrophage colony-stimulating factor 1; lanimostim

Target 2

IL34

Gene ID

146433

UniProt ID

Q6ZMJ4

Alternative Names

IL-34; C16orf77; interleukin 34

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-CSF1 x Anti-IL34 Bispecific Antibody (IgG-Fv) (BSGV-143). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-CSF1 x Anti-IL34 Bispecific Antibody (IgG-Fv) (CAT#: BSGV-143)

Specifications

Targets

Customer Reviews and Q&As